nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
AACR: Science, policy and … clinical data
|
|
|
|
10 |
6 |
p. 611-617 |
artikel |
2 |
AACR: Science, policy and... clinical data; NCI to restructure drugdevelopment program; A strategy meeting on cancer research in Europe; WHOpreparing code on bioethics; Perhaps not everyone knows that...; Death toll:5,000 children a month
|
|
|
1999 |
10 |
6 |
p. 611-617 7 p. |
artikel |
3 |
A. Manni (ed)., Endocrinology of breast cancer
|
M. Colleoni |
|
1999 |
10 |
6 |
p. 737-737 1 p. |
artikel |
4 |
Antibody therapy has arrived. Now where does it fit?
|
Maloney, D.G. |
|
|
10 |
6 |
p. 619-621 |
artikel |
5 |
Antibody therapy has arrived. Now where does it fit?
|
D. G. Maloney |
|
1999 |
10 |
6 |
p. 619-621 3 p. |
artikel |
6 |
A randomized crossover trial assessing patient preference for two different types of portable infusion-pump devices
|
Zahnd, D. |
|
|
10 |
6 |
p. 727-729 |
artikel |
7 |
A randomized crossover trial assessing patient preference for twodifferent types of portable infusion-pump devices
|
D. Zahnd |
|
1999 |
10 |
6 |
p. 727-729 3 p. |
artikel |
8 |
Book review
|
Colleoni, M. |
|
|
10 |
6 |
p. 737 |
artikel |
9 |
Book review
|
Longo, D. |
|
|
10 |
6 |
p. 617-618 |
artikel |
10 |
Book review
|
Spataro, V. |
|
|
10 |
6 |
p. 622 |
artikel |
11 |
Book review
|
Bertoni, F. |
|
|
10 |
6 |
p. 626 |
artikel |
12 |
Concurrent platinum-based chemo- and radiotherapy for locally advanced cervical cancer: A new gold-standard treatment?
|
Mangioni, C. |
|
|
10 |
6 |
p. 647-648 |
artikel |
13 |
Concurrent platinum-based chemo- and radiotherapy for locally advancedcervical cancer: A new gold-standard treatment?
|
C. Mangioni |
|
1999 |
10 |
6 |
p. 647-648 2 p. |
artikel |
14 |
Contents of the next issue
|
|
|
|
10 |
6 |
p. xxvii |
artikel |
15 |
Copyright
|
|
|
|
10 |
6 |
p. xxv |
artikel |
16 |
Depression in breast cancer patients: The need for treatment
|
Aapro, M. |
|
|
10 |
6 |
p. 627-636 |
artikel |
17 |
Depression in breast cancer patients: The need for treatment
|
M. Aapro |
|
1999 |
10 |
6 |
p. 627-636 10 p. |
artikel |
18 |
Doxil extravasation injury: A case report
|
J. Lokich |
|
1999 |
10 |
6 |
p. 735-736 2 p. |
artikel |
19 |
Editorial Board
|
|
|
|
10 |
6 |
p. xxvi |
artikel |
20 |
Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma
|
Piro, L.D. |
|
|
10 |
6 |
p. 655-661 |
artikel |
21 |
Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsedor refractory low-grade or follicular non-Hodgkins lymphoma
|
L. D. Piro |
|
1999 |
10 |
6 |
p. 655-661 7 p. |
artikel |
22 |
Five-year leukemia survival by age
|
Levi, J. |
|
|
10 |
6 |
p. 735-736 |
artikel |
23 |
Five-year leukemia survival by age
|
F. Levi |
|
1999 |
10 |
6 |
p. 735-735 1 p. |
artikel |
24 |
Gastric MALT lymphoma: From concept to cure
|
Isaacson, P.G. |
|
|
10 |
6 |
p. 637-645 |
artikel |
25 |
Gastric MALT lymphoma: From concept to cure
|
P. G. Isaacson |
|
1999 |
10 |
6 |
p. 637-645 9 p. |
artikel |
26 |
In this issue
|
|
|
|
10 |
6 |
p. xxvii |
artikel |
27 |
J. G. Monroe, E. V. Rothenberg (eds)., Molecular biology of B-cell andT-cell development
|
F. Bertoni |
|
1999 |
10 |
6 |
p. 626-626 1 p. |
artikel |
28 |
J. H. Goldie, A. J. Coldman., Drug resistance in cancer. Mechanisms andmodels.
|
V. Spataro |
|
1999 |
10 |
6 |
p. 622-622 1 p. |
artikel |
29 |
L. Degos, D. C. Linch & B. Lowenberg (eds)., Textbook of malignanthaematology
|
D. Longo |
|
1999 |
10 |
6 |
p. 617-618 2 p. |
artikel |
30 |
Long-term evolution of renal function in patients with ovarian cancer after whole abdominal irradiation with or without preceding cisplatin*
|
Schneider, D.P. |
|
|
10 |
6 |
p. 677-683 |
artikel |
31 |
Long-term evolution of renal function in patients with ovarian cancerafter whole abdominal irradiation with or without preceding cisplatin
|
D. P. Schneider |
|
1999 |
10 |
6 |
p. 677-683 7 p. |
artikel |
32 |
Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery
|
Giacchetti, S. |
|
|
10 |
6 |
p. 663-669 |
artikel |
33 |
Long-term survival of patients with unresectable colorectal cancer livermetastases following infusional chemotherapy with 5-fluorouracil, leucovorin,oxaliplatin and surgery
|
S. Giacchetti |
|
1999 |
10 |
6 |
p. 663-669 7 p. |
artikel |
34 |
Neoadjuvant chemotherapy for unresectable liver metastases of colorectal cancer-too good to be true?
|
Borner, M.M. |
|
|
10 |
6 |
p. 623-626 |
artikel |
35 |
Neoadjuvant chemotherapy for unresectable liver metastases of colorectalcancer too good to be true?
|
M. M. Borner |
|
1999 |
10 |
6 |
p. 623-626 4 p. |
artikel |
36 |
Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: A randomized phase III study conducted by the Hellenic Cooperative Oncology Group
|
Fountzilas, G. |
|
|
10 |
6 |
p. 671-676 |
artikel |
37 |
Postoperative radiation and concomitant bolus fluorouracil with orwithout additional chemotherapy with fluorouracil and high-dose leucovorin inpatients with high-risk rectal cancer: A randomized phase III study conductedby the Hellenic Cooperative Oncology Group
|
G. Fountzilas |
|
1999 |
10 |
6 |
p. 671-676 6 p. |
artikel |
38 |
Progressive disease rate as a surrogate endpoint of phase II trials for non-small-cell lung cancer
|
Sekine, I. |
|
|
10 |
6 |
p. 731-733 |
artikel |
39 |
Progressive disease rate as a surrogate endpoint of phase II trials fornon-small-cell lung cancer
|
I. Sekine |
|
1999 |
10 |
6 |
p. 731-733 3 p. |
artikel |
40 |
Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer
|
Planting, A.S.T. |
|
|
10 |
6 |
p. 693-700 |
artikel |
41 |
Randomized study of a short course of weekly cisplatin with or withoutamifostine in advanced head and neck cancer
|
A. S. T. Planting |
|
1999 |
10 |
6 |
p. 693-700 8 p. |
artikel |
42 |
Sixty percent salvage rate for germ-cell tumours using sequential m-BOP, surgery and ifosfamide-based chemotherapy
|
Shamash, J. |
|
|
10 |
6 |
p. 685-692 |
artikel |
43 |
Sixty percent salvage rate for germ-cell tumours using sequential m-BOP,surgery and ifosfamide-based chemotherapy
|
J. Shamash |
|
1999 |
10 |
6 |
p. 685-692 8 p. |
artikel |
44 |
Table of Contents
|
|
|
|
10 |
6 |
p. xxv |
artikel |
45 |
T-cell prolymphocytic leukaemia: Does the expression of CD8+ phenotype justify the identification of a new subtype?
|
Ascani, S. |
|
|
10 |
6 |
p. 649-653 |
artikel |
46 |
T-cell prolymphocytic leukaemia: Does the expression of CD8+ phenotypejustify the identification of a new subtype?
|
S. Ascani |
|
1999 |
10 |
6 |
p. 649-653 5 p. |
artikel |
47 |
Telomerase activity distinguishes between neuroblastomas with good andpoor prognosis
|
C. Poremba |
|
1999 |
10 |
6 |
p. 715-721 7 p. |
artikel |
48 |
Telomerase activity distinguishes between neuroblastomas with poor prognosis
|
Poremba, C. |
|
|
10 |
6 |
p. 715-721 |
artikel |
49 |
The role of chemotherapy in intracranial germinoma: A case report
|
Hupperets, P.S.G.J. |
|
|
10 |
6 |
p. 723-726 |
artikel |
50 |
The role of chemotherapy in intracranial germinoma: A case report
|
P. S. G. J. Hupperets |
|
1999 |
10 |
6 |
p. 723-726 4 p. |
artikel |
51 |
Upregulation of basic fibroblast growth factor in breast carcinoma and its relationship to vascular density, oestrogen receptor, epidermal growth factor receptor and survival
|
Smith, K. |
|
|
10 |
6 |
p. 707-713 |
artikel |
52 |
Upregulation of basic fibroblast growth factor in breast carcinoma andits relationship to vascular density, oestrogen receptor, epidermal growthfactor receptor and survival
|
K. Smith |
|
1999 |
10 |
6 |
p. 707-713 7 p. |
artikel |
53 |
Weekly docetaxel in minimally pretreated cancer patients: A dose-escalation study focused on feasibility and cumulative toxicity of long-term administration
|
Briasoulis, E. |
|
|
10 |
6 |
p. 701-706 |
artikel |
54 |
Weekly docetaxel in minimally pretreated cancer patients: Adose-escalation study focused on feasibility and cumulative toxicity oflong-term administration
|
E. Briasoulis |
|
1999 |
10 |
6 |
p. 701-706 6 p. |
artikel |